Myeloma Crowd Radio

Myeloma Crowd Radio brings you patient-led interviews of the world's top multiple myeloma researchers. Call in live at showtime to (347) 637-2631 ask questions and to learn about the latest innovation in simple terms patients can understand.

http://www.blogtalkradio.com/myelomacrowdradio

subscribe
share



 
 

      episode 12: Myeloma Crowd Radio: Ashraf Badros, MD, University of Maryland


      Let's talk about multiple myeloma in the African American community


      share





         1h20m
       
       

      episode 11: Myeloma Crowd: Irene Ghobrial, MD, Dana Farber Cancer Institute


      A 50,000 patient and family study for early precursor myeloma conditions


      share





         1h5m
       
       

      episode 10: Myeloma Crowd Radio: Maria Chaudhry, MD, Ohio State University


      Learn more about the new GSK antibody for relapsed/refractory multiple myeloma


      share





       2018-09-13  1h0m
       
       

      episode 9: Myeloma Crowd: Paul Richardson, MD, Dana Farber Cancer Institute


      Mid-Year Review for Multiple Myeloma


      share





       2018-08-03  1h28m
       
       

      episode 8: Myeloma Crowd Radio: Brian McMahon of SparkCures (rescheduled)


      How to get into popular myeloma clinical trials


      share





       2018-07-30  1h14m
       
       

      episode 6: Myeloma Crowd Radio: Muhamed Baljevic, MD, University of Nebraska Medical Center


      Many myeloma patients can become resistant to an important class of myeloma drugs called proteasome inhibitors. Here's a new drug that may help overcome resista


      share





       2018-05-28  1h6m
       
       

      episode 5: Myeloma Crowd Radio: HealthTree With Rafael Fonseca, MD, Mayo Clinic


      HealthTree is a new tool for multiple myeloma patients to find optimal treatment options and accelerate a cure


      share





       2018-05-18  1h7m
       
       

      episode 4: Myeloma Crowd Radio: Luciano Costa, MD, PhD, University of Alabama


      How can newly diagnosed myeloma patients best get into remission? Here's an important study using key up-front therapies.


      share





       2018-04-16  1h0m
       
       

      episode 3: Myeloma Crowd Radio: Veronika Bachanova, MD, PhD, University of Minnesota


      Using donor Natural Killer cells with Elotuzumab in a Myeloma Clinical Trial


      share





       2018-03-12  51m
       
       

      episode 2: Myeloma Crowd Radio: William Matsui, MD, Johns Hopkins University


      Making allo transplant safer and more effective while also targeting precursor myeloma cells


      share





       2018-02-16  1h10m